Supplemental material
Human Vaccines & Immunotherapeutics
Volume 15, 2019 - Issue 12
Research Paper
Evaluation of two frailty indices, with practical application in a vaccine clinical trial
Desmond Currana GSK, Wavre, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0002-7423-0111View further author information
https://orcid.org/0000-0002-7423-0111View further author information, Melissa K. Andrewb Division of Geriatric Medicine, Dalhousie University, Halifax, Nova Scotia, Canadahttps://orcid.org/0000-0001-7514-8972View further author information
https://orcid.org/0000-0001-7514-8972View further author information, Myron J. Levinc Departments of Pediatrics and Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USAhttps://orcid.org/0000-0002-7468-106XView further author information
https://orcid.org/0000-0002-7468-106XView further author information, Elisa Turriania GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-0114-065XView further author information
https://orcid.org/0000-0002-0114-065XView further author information, Sean Matthewsd Freelance c/o GSK, Wavre, Belgiumhttps://orcid.org/0000-0001-7427-7326View further author information
https://orcid.org/0000-0001-7427-7326View further author information, , , Katrijn Gruppinga GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-3300-1021View further author information
https://orcid.org/0000-0002-3300-1021View further author information, Lidia Oostvogelsa GSK, Wavre, Belgiumhttps://orcid.org/0000-0003-1298-0360View further author information
https://orcid.org/0000-0003-1298-0360View further author information & Kenneth E. Schmaderg Division of Geriatrics, Duke University Medical Center and GRECC, Durham Veterans Affairs Medical Center, Durham, NC, USAhttps://orcid.org/0000-0001-5036-2155View further author information
https://orcid.org/0000-0001-5036-2155View further author information show allRelated Research Data
Frailty and quality of life: a cross-sectional study of Brazilian patients with pre-dialysis chronic kidney disease
Source:
Springer Nature
MOCA: A BRIEF SCREENING TOOL FOR MCI
Source:
Wiley
FRAILTY PREVALENCE AND OUTCOME
Source:
Wiley
The frailty phenotype and the frailty index: different instruments for different purposes
Source:
Oxford University Press (OUP)
Frailty in Older Adults Evidence for a Phenotype
Source:
Oxford University Press (OUP)
Quality of life impact of an adjuvanted recombinant zoster vaccine in adults aged 50 years and older
Source:
Oxford University Press (OUP)
Better influenza vaccines for older people: what will it take?
Source:
Oxford University Press (OUP)
The temporal impact of aging on the burden of herpes zoster
Source:
Springer Science and Business Media LLC
Prevention in the elderly: A necessary priority for general practitioners.
Source:
Taylor & Francis Group
FITNESS AND FRAILTY IN RELATION TO MORTALITY
Source:
Wiley
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Source:
MASSACHUSETTS MEDICAL SOC
Influence of Age and Nature of Primary Infection on Varicella-Zoster Virus—Specific Cell-Mediated Immune Responses
Source:
Oxford University Press (OUP)
VZV T Cell-Mediated Immunity
Source:
Springer Berlin Heidelberg
Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.
Source:
Springer Science and Business Media LLC
Accumulation of deficits as a proxy measure of aging.
Source:
Hindawi Limited
Linking provided by
